Clinical trial
Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to…
NCT00154193 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00154193 |
|---|---|
| Title | Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels |
| Official title | A 12-month Study to Investigate the Correlations Between Cyclosporine Microemulsion C2 Levels (High, Medium and Low) and AUC0-4 With Regard to Outcome in de Novo Heart and Lung Transplantation - Identification of Target Cyclosporine Microemulsion C2 Levels. |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart and Lung Transplant |
| Intervention type | Drug |
| Interventions | cyclosporine |
| Enrollment | 190 |
| Start date | Jun 1, 2004 |
| Primary completion | Nov 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 11, 2020 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: